SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:umu-211993"
 

Sökning: onr:"swepub:oai:DiVA.org:umu-211993" > Circulating insulin...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00019890naa a2201129 4500
001oai:DiVA.org:umu-211993
003SwePub
008230712s2023 | |||||||||||000 ||eng|
009oai:DiVA.org:uu-524535
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-2119932 URI
024a https://doi.org/10.1093/ije/dyac1242 DOI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5245352 URI
040 a (SwePub)umud (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Watts, Eleanor L.u Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom4 aut
2451 0a Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer :b a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
264 c 2022-06-21
264 1b Oxford University Press,c 2023
338 a electronic2 rdacarrier
520 a Background: Previous studies had limited power to assess the associations of circulating insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) with clinically relevant prostate cancer as a primary endpoint, and the association of genetically predicted IGF-I with aggressive prostate cancer is not known. We aimed to investigate the associations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 concentrations with overall, aggressive and early-onset prostate cancer.Methods: Prospective analysis of biomarkers using the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group dataset (up to 20 studies, 17 009 prostate cancer cases, including 2332 aggressive cases). Odds ratios (OR) and 95% confidence intervals (CI) for prostate cancer were estimated using conditional logistic regression. For IGF-I, two-sample Mendelian randomization (MR) analysis was undertaken using instruments identified using UK Biobank (158 444 men) and outcome data from PRACTICAL (up to 85 554 cases, including 15 167 aggressive cases). Additionally, we used colocalization to rule out confounding by linkage disequilibrium.Results: In observational analyses, IGF-I was positively associated with risks of overall (OR per 1 SD = 1.09: 95% CI 1.07, 1.11), aggressive (1.09: 1.03, 1.16) and possibly early-onset disease (1.11: 1.00, 1.24); associations were similar in MR analyses (OR per 1 SD = 1.07: 1.00, 1.15; 1.10: 1.01, 1.20; and 1.13; 0.98, 1.30, respectively). Colocalization also indicated a shared signal for IGF-I and prostate cancer (PP4: 99%). Men with higher IGF-II (1.06: 1.02, 1.11) and IGFBP-3 (1.08: 1.04, 1.11) had higher risks of overall prostate cancer, whereas higher IGFBP-1 was associated with a lower risk (0.95: 0.91, 0.99); these associations were attenuated following adjustment for IGF-I.Conclusions: These findings support the role of IGF-I in the development of prostate cancer, including for aggressive disease.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Urologi och njurmedicin0 (SwePub)302142 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Urology and Nephrology0 (SwePub)302142 hsv//eng
653 a aggressive prostate cancer
653 a Insulin-like growth factor-I
653 a international consortia
653 a Mendelian randomization
653 a prospective analysis
653 a prostate cancer
700a Perez-Cornago, Aurorau Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom,Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England.4 aut
700a Fensom, Georgina K.u Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom,Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England.4 aut
700a Smith-Byrne, Karlu Genomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France,Int Agcy Res Canc, Genom Epidemiol Branch, Lyon, France.4 aut
700a Noor, Urwahu Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom,Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England.4 aut
700a Andrews, Colm D.u Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom,Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England.4 aut
700a Gunter, Marc J.u Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France,Int Agcy Res Canc, Sect Nutr & Metab, Lyon, France.4 aut
700a Holmes, Michael V.u Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom; Medical Research Council Population Health Research Unit, University of Oxford, Oxford, United Kingdom,Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England.;Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTS, Oxford, England.;Univ Oxford, Med Res Council Populat Hlth Res Unit, Oxford, England.4 aut
700a Martin, Richard M.u Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom; MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, United Kingdom; National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, Univ. Hospitals Bristol NHS Found. Trust and Weston NHS Foundation Trust and University of Bristol, Bristol, United Kingdom,Univ Bristol, Bristol Med Sch, Dept Populat Hlth Sci, Bristol, Avon, England.;Univ Bristol, Bristol Med Sch, MRC Integrat Epidemiol Unit IEU, Bristol, Avon, England.;Univ Hosp Bristol NHS Fdn Trust & Weston NHS Fdn, Natl Inst Hlth Res NIHR Bristol Biomed Res Ctr, Bristol, Avon, England.4 aut
700a Tsilidis, Konstantinos K.u Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece,Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.;Univ Ioannina, Dept Hyg & Epidemiol, Sch Med, Ioannina, Greece.4 aut
700a Albanes, Demetriusu Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States,NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.;CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.4 aut
700a Barricarte, Aureliou Group of Epidemiology of Cancer and Other Chronic Diseases, Navarra Public Health Institute, Pamplona, Spain; Group of Epidemiology of Cancer and Other Chronic Diseases, Navarra Institute for Health Research (IdiSNA), Pamplona, Spain; CIBER Epidemiology and Public Health CIBERESP, Madrid, Spain,Navarra Publ Hlth Inst, Grp Epidemiol Canc & Other Chron Dis, Pamplona, Spain.;Navarra Inst Hlth Res IdiSNA, Grp Epidemiol Canc & Other Chron Dis, Pamplona, Spain.4 aut
700a Bueno-De-Mesquita, H. Basu Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment (RIVM), Utrecht, Netherlands,Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Utrecht, Netherlands.4 aut
700a Cohn, Barbara A.u Child Health and Development Studies, Public Health Institute, CA, Berkeley, United States,Inst Publ Hlth, Child Hlth & Dev Studies, Berkeley, CA USA.4 aut
700a Deschasaux-Tanguy, Melanieu Sorbonne Paris Nord University, Nutritional Epidemiology Research Team, Epidemiology and Statistics Research Center, University of Paris, Bobigny, France,Univ Paris, Sorbonne Paris Nord Univ, Epidemiol & Stat Res Ctr, Nutr Epidemiol Res Team, Bobigny, France.4 aut
700a Dimou, Niki L.u Section of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France,Int Agcy Res Canc, Sect Nutr & Metab, Lyon, France.4 aut
700a Ferrucci, Luigiu National Institute on Aging, MD, Baltimore, United States,NIA, Baltimore, MD 21224 USA.4 aut
700a Flicker, Leonu WA Centre for Health & Ageing, Medical School, University of Western Australia, WA, Perth, Australia; Western Australian Centre for Health and Ageing, University of Western Australia, WA, Perth, Australia,Univ Western Australia, Sch Med, WA Ctr Hlth & Ageing, Perth, WA, Australia.;Univ Western Australia, Western Australian Ctr Hlth & Ageing, Perth, WA, Australia.4 aut
700a Freedman, Neal D.u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States,NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.4 aut
700a Giles, Graham G.u Cancer Epidemiology Division, Cancer Council Victoria, VIC, Melbourne, Australia; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, VIC, Melbourne, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, VIC, Melbourne, Australia,Canc Council Victoria, Canc Epidemiol Div, Melbourne, Vic, Australia.;Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia.;Monash Univ, Sch Clin Sci, Precis Med, Monash Hlth, Melbourne, Vic, Australia.4 aut
700a Giovannucci, Edward L.u Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, MA, Boston, United States; Department of Nutrition, Harvard T.H. Chan School of Public Health, MA, Boston, United States,Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.;Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.;Harvard Med Sch, Boston, MA 02115 USA.;Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.4 aut
700a Haiman, Christopher A.u Department of Preventive Medicine, Center for Genetic Epidemiology, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, CA, Los Angeles, United States,Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Norris Comprehens Canc Ctr,Ctr Genet Epidemiol, Los Angeles, CA USA.4 aut
700a Hankey, Graham J.u WA Centre for Health & Ageing, Medical School, University of Western Australia, WA, Perth, Australia,Univ Western Australia, Western Australian Ctr Hlth & Ageing, Perth, WA, Australia.4 aut
700a Holly, Jeffrey M. P.u IGFs & Metabolic Endocrinology Group, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom,Univ Bristol, Bristol Med Sch, IGFs Metab Endocrinol Grp, Translat Hlth Sci, Bristol, Avon, England.4 aut
700a Huang, Jiaqiu Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States; National Clinical Research Center for Metabolic Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, Department of Metabolism and Endocrinology, Second Xiangya Hospital of Central South University, Changsha, Hunan, China,NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.;Cent South Univ, Natl Clin Res Ctr Metab Dis, Key Lab Diabet Immunol, Minist Educ, Changsha, Hunan, Peoples R China.;Cent South Univ, Xiangya Hosp 2, Dept Endocrinol & Metab, Changsha, Hunan, Peoples R China.4 aut
700a Huang, Wen-Yiu Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States,NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.4 aut
700a Hurwitz, Lauren M.u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States,NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.4 aut
700a Kaaks, Rudolfu Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany,German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany.4 aut
700a Kubo, Tatsuhikou Department of Public Health and Health Policy, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan,Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan.4 aut
700a Le Marchand, Loicu University of Hawaii, Cancer Center, HI, Honolulu, United States,Univ Hawaii, Ctr Canc, Honolulu, HI USA.4 aut
700a Macinnis, Robert J.u Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, VIC, Melbourne, Australia; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, VIC, Melbourne, Australia,Monash Univ, Sch Clin Sci, Precis Med, Monash Hlth, Melbourne, Vic, Australia.;Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.4 aut
700a Männistö, Satuu Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland,Finnish Inst Hlth & Welf, Dept Publ Hlth & Welf, Helsinki, Finland.4 aut
700a Metter, E. Jeffreyu Department of Neurology, College of Medicine, University of Tennessee Health Science Center, TN, Memphis, United States,Univ Tennessee Hlth Sci Ctr, Dept Neurol, Coll Med, Memphis, TN USA.4 aut
700a Mikami, Kazuyau Departmemt of Urology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan,Japanese Red Cross Kyoto Daiichi Hosp, Dept Urol, Kyoto, Japan.4 aut
700a Mucci, Lorelei A.u Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States,Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.4 aut
700a Olsen, Anja W.u Department of Public Health, Aarhus University, Aarhus, Denmark; Danish Cancer Society, Research Center, Copenhagen, Denmark,Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.;Danish Canc Soc, Res Ctr, Copenhagen, Denmark.4 aut
700a Ozasa, Kotarou Departmemt of Epidemiology, Radiation Effects Research Foundation, Hiroshima, Japan,Radiat Effects Res Fdn, Dept Epidemiol, Hiroshima, Japan.4 aut
700a Palli, Domenicou Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, Florence, Italy,Inst Canc Res, Canc Risk Factors & Life Style Epidemiol Unit, Prevent & Clin Network, Florence, Italy.4 aut
700a Penney, Kathryn L.u Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, MA, Boston, United States,Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.;Harvard Med Sch, Boston, MA 02115 USA.4 aut
700a Platz, Elizabeth A.u Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, MD, Baltimore, United States,Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.4 aut
700a Pollak, Michael N.u Departments of Medicine and Oncology, McGill University, QC, Montreal, Canada,McGill Univ, Dept Med, Montreal, PQ, Canada.4 aut
700a Roobol, Monique J.u Department of Urology, Erasmus University Medical Center, Rotterdam, Netherlands,McGill Univ, Dept Oncol, Montreal, PQ, Canada.4 aut
700a Schaefer, Catherine A.u Division of Research, Kaiser Permanente Northern California, CA, Oakland, United States,Erasmus MC, Dept Urol, Rotterdam, Netherlands.4 aut
700a Schenk, Jeannette M.u Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, WA, Seattle, United States,Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA.4 aut
700a Stattin, Päru Uppsala universitet,Urologkirurgi4 aut0 (Swepub:uu)parst892
700a Tamakoshi, Akikou Department of Public Health, Faculty of Medicine, Hokkaido University , Sapporo, Japan4 aut
700a Thysell, Elinu Umeå universitet,Patologi,Hokkaido Univ, Dept Publ Hlth, Fac Med, Sapporo, Hokkaido, Japan.4 aut0 (Swepub:umu)elnsjn00
700a Tsai, Chiaojung Jillianu Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, NY, New York, United States,Umeå Univ, Dept Med Biosci, Umeå, Sweden.4 aut
700a Touvier, Mathildeu Sorbonne Paris Nord University, Nutritional Epidemiology Research Team, Epidemiology and Statistics Research Center, University of Paris, Bobigny, France4 aut
700a Van Den Eeden, Stephen K.u Division of Research, Kaiser Permanente Northern California, CA, Oakland, United States; Department of Urology, University of California San Francisco, CA, San Francisco, United States,Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA.4 aut
700a Weiderpass, Elisabeteu Director's Office, International Agency for Research on Cancer, World Health Organization, Lyon, France,Univ Calif San Francisco, Dept Urol, San Francisco, CA USA.4 aut
700a Weinstein, Stephanie J.u Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, MD, Bethesda, United States4 aut
700a Wilkens, Lynne R.u University of Hawaii, Cancer Center, HI, Honolulu, United States4 aut
700a Yeap, Bu B.u WA Centre for Health & Ageing, Medical School, University of Western Australia, WA, Perth, Australia; Department of Endocrinology and Diabetes, Fiona Stanley Hospital, WA, Perth, Australia,Int Agcy Res Canc, Directors Off, WHO, Lyon, France.4 aut
700a Allen, Naomi E.u Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom; UK Biobank Ltd, Stockport, United Kingdom,Fiona Stanley Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia.;UK Biobank Ltd, Stockport, Lancs, England.4 aut
700a Key, Timothy J.u Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom,Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England.4 aut
700a Travis, Ruth C.u Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom,Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England.4 aut
710a Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdomb Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford, England.4 org
773t International Journal of Epidemiologyd : Oxford University Pressg 52:1, s. 71-86q 52:1<71-86x 0300-5771x 1464-3685
856u https://doi.org/10.1093/ije/dyac124y Fulltext
856u https://umu.diva-portal.org/smash/get/diva2:1782115/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
856u https://uu.diva-portal.org/smash/get/diva2:1844533/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-211993
8564 8u https://doi.org/10.1093/ije/dyac124
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-524535

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy